GSK plc has grown revenue 3.7% a year over three years and 6.0% a year over five, with earnings per share compounding at −28%. Revenue growth, 3-year annual rate: +3.7% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +6.0%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −28%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 11, FY2015 to FY2025, as filed.

GSKGSK plc

HealthcareUSD

$51.44

$36.3552 weeks$60.14

Is it growing?

Is GSK growing?

GSK plc has grown revenue 3.7% a year over three years and 6.0% a year over five, with earnings per share compounding at −28%.

+3.7%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from fiscal years as filed

Revenue growth, 5-year rate: +6.0%
Revenue growth, 5-year rate · +3.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −28%
Earnings per share, 3-year rate · revenue +3.7% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed